Skip to main content

Table 6 Multivariate analysis for different COPD exacerbation statuses with a 2-year follow-up

From: The predictive value of baseline symptom score and the peripheral CD4CD8 double-positive T cells in patients with AECOPD

Variables

Degree of exacerbation

Mild Exacerbators

Moderate Exacerbators

Severe Exacerbators

Odds Ratio (95% CI)

P value

Odds Ratio (95% CI)

P value

Odds Ratio (95% CI)

P value

Home oxygen therapy

2.12(0.60,7.48)

0.24

0.55(0.06,5.45)

0.61

2.71(1.12,6.57)

0.03

SGRQ score

1.04(0.99,1.10)

0.13

1.05(0.98,1.13)

0.15

1.01(0.97,1.05)

0.66

mMRC score

0.99(0.41,2.38)

0.98

0.44(0.11,1.81)

0.26

1.13(0.61,2.08)

0.70

CAT score

0.89(0.77,1.03)

0.12

0.93(0.76,1.12)

0.43

0.99(0.89,1.10)

0.81

COPD-related exacerbation within the previous year

0.80(0.36,1.76)

0.58

1.43(0.61,3.32)

0.41

1.71(1.10,2.65)

0.02

  1. Multiple logistic regression was used
  2. OR odds ratio, CI confidence interval, Max maximum, Min minimum, COPD chronic obstructive pulmonary disease, SGRQ St George's respiratory questionnaire, mMRC modified medical research council, CAT chronic obstructive pulmonary disease assessment test